Improved effect of tolbutamide when given before food in patients on long-term therapy.
作者信息
Samanta A, Jones G R, Burden A C, Shakir I
出版信息
Br J Clin Pharmacol. 1984 Oct;18(4):647-8. doi: 10.1111/j.1365-2125.1984.tb02522.x.
Abstract
摘要
相似文献
1
Improved effect of tolbutamide when given before food in patients on long-term therapy.
Br J Clin Pharmacol. 1984 Oct;18(4):647-8. doi: 10.1111/j.1365-2125.1984.tb02522.x.
2
Short term tolbutamide therapy in early diabetes mellitus.
Bull Calcutta Sch Trop Med. 1968 Apr;16(2):33-5.
3
Tolbutamide for maturity-onset diabetics: a clinical comparison of a single-dose versus a divided-dose schedule.
S Afr Med J. 1968 Dec 7;42(46):1257-8.
4
Effect of intravenous tolbutamide on serum insulin levels in pancreatic diabetes.
Diabetes. 1969 Jul;18(7):499-501. doi: 10.2337/diab.18.7.499.
5
Glibenclamide therapy in diabetes mellitus.
Br Med J. 1970 Jun 6;2(5709):570-2. doi: 10.1136/bmj.2.5709.570.
6
Metabolic studies in diabetics on tolbutamide. Comparison of a single dose with a divided dose regimen.
Diabetologia. 1968 Aug;4(4):203-9. doi: 10.1007/BF00430096.
7
[On the problem of tolbutamide dosage in the oral treatment of diabetes mellitus, simultaneously on the problem of late failure].
Dtsch Z Verdau Stoffwechselkr. 1967 Feb;26(4):175-80.
8
A clinical comparison of the potency of acetohexamide and tolbutamide.
Curr Ther Res Clin Exp. 1969 May;11(5):227-33.
9
[Pre-, intra- and postoperative control of metabolism in diabetics using intravenous administration of tolbutamide].
Zentralbl Chir. 1974 Jan 18;99(18):82-6.
10
[Diminution of delay in insulin secretion in early diabetes mellitus with ongoing tolbutamide treatment].
Union Med Can. 1974 Mar;103(3):413-7.
引用本文的文献
1
Insulinotropic effect of the non-steroidal compound STX in pancreatic β-cells.
PLoS One. 2012;7(4):e34650. doi: 10.1371/journal.pone.0034650. Epub 2012 Apr 10.
2
Effects of food on clinical pharmacokinetics.
Clin Pharmacokinet. 1999 Sep;37(3):213-55. doi: 10.2165/00003088-199937030-00003.
3
Is there a concentration-effect relationship for sulphonylureas?
Clin Pharmacokinet. 1998 Mar;34(3):181-8. doi: 10.2165/00003088-199834030-00001.
4
The relationship between the pharmacokinetics and pharmacodynamic effects of oral hypoglycaemic drugs.
Clin Pharmacokinet. 1987 Jun;12(6):379-401. doi: 10.2165/00003088-198712060-00001.
5
Sulphonylurea antidiabetic drugs. An update of their clinical pharmacology and rational therapeutic use.
Drugs. 1989 Jan;37(1):58-72. doi: 10.2165/00003495-198937010-00004.
6
The effects of ingestion time of gliclazide in relationship to meals on plasma glucose, insulin and C-peptide levels.
Eur J Clin Pharmacol. 1990;38(5):465-7. doi: 10.1007/BF02336685.
7
Pharmacokinetic and pharmacodynamic studies of glibenclamide in non-insulin dependent diabetes mellitus.
Br J Clin Pharmacol. 1990 Jun;29(6):673-84. doi: 10.1111/j.1365-2125.1990.tb03688.x.
8
Effect of magnesium hydroxide on the absorption and efficacy of tolbutamide and chlorpropamide.
Eur J Clin Pharmacol. 1992;42(6):675-9. doi: 10.1007/BF00265936.
本文引用的文献
1
Therapeutic review: harmony with drugs with food.
Can Med Assoc J. 1982 May 15;126(10):1161-2.
2
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
Drugs. 1981 Sep;22(3):211-45. doi: 10.2165/00003495-198122030-00003.
3
Influence of food intake on the absorption and effect of glipizide in diabetics and in healthy subjects.
Eur J Clin Pharmacol. 1980 Oct;18(3):279-83. doi: 10.1007/BF00563012.
4
Influence of food and age on the single-dose kinetics and effects of tolbutamide and chlorpropamide.
Eur J Clin Pharmacol. 1980 Apr;17(4):285-93. doi: 10.1007/BF00625802.
5
Improved effect of glibenclamide on administration before breakfast.
Eur J Clin Pharmacol. 1982;21(5):403-8. doi: 10.1007/BF00542327.
6
Sulfonylurea drugs: mechanism of antidiabetic action and therapeutic usefulness.
Diabetes Care. 1978 May-Jun;1(3):189-98. doi: 10.2337/diacare.1.3.189.
Zotero 插件